These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1750596)

  • 41. Postoperative malignant hyperthermia and dantrolene therapy.
    Schulte-Sasse U; Hess W; Eberlein HJ
    Can Anaesth Soc J; 1983 Nov; 30(6):635-40. PubMed ID: 6640400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [S1 guidelines on malignant hyperthermia : Update 2018].
    Wappler F
    Anaesthesist; 2018 Jul; 67(7):529-532. PubMed ID: 29943228
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delayed Development of Malignant Hyperthermia Following Cardiopulmonary Bypass.
    Sams SH; Revilla S; Stahl DL
    Semin Cardiothorac Vasc Anesth; 2018 Mar; 22(1):95-99. PubMed ID: 28922985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].
    Urwyler A; Censier K; Seeberger MD; Drewe J; Rothenbühler JM; Frei F
    Schweiz Med Wochenschr; 1991 Apr; 121(16):566-71. PubMed ID: 2042040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malignant hyperthermia: clinical course and metabolic changes in two patients.
    Rutberg H; Håkanson E
    Acta Anaesthesiol Scand; 1986 Apr; 30(3):211-4. PubMed ID: 3739577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dantrium: the approved drug to control malignant hyperthermia.
    Gever LN
    Nursing; 1980 Jul; 10(7):62. PubMed ID: 6900937
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of dantrolene on leg metabolism in porcine malignant hyperthermia.
    Hall GM; Lucke JN; Orchard C; Lovell R; Lister D
    Anaesthesia; 1982 Dec; 37(12):1167-70. PubMed ID: 7181063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant hyperthermia with excellent response to small dose of dantrolene.
    Chang KY; Ting CK; Chan KH; Tsai SK
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):241-5. PubMed ID: 15679136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
    Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. End-tidal CO2 monitoring. Its use in the diagnosis and management of malignant hyperthermia.
    Baudendistel L; Goudsouzian N; Cote' C; Strafford M
    Anaesthesia; 1984 Oct; 39(10):1000-3. PubMed ID: 6437267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dantrolene in porcine malignant hyperthermia.
    Gronert GA; Milde JH; Theye RA
    Anesthesiology; 1976 Jun; 44(6):488-95. PubMed ID: 1275316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phaeochromocytoma in a malignant hyperthermia patient under anaesthesia.
    Wajon P
    Anaesth Intensive Care; 1990 Nov; 18(4):570-4. PubMed ID: 2268028
    [No Abstract]   [Full Text] [Related]  

  • 53. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
    Harrison GG
    Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Masseter muscle rigidity after suxamethonium during induction and postoperative abortive malignant hyperthermia in a patient with esophageal achalasia].
    Arakawa Y; Kuroiwa M; Anzai T; Kanai A; Okamoto H; Hoka S
    Masui; 2004 Mar; 53(3):287-90. PubMed ID: 15071881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Acute postoperative sepsis mimicking symptomology suspicious for malignant hyperthermia: case report].
    Ramanujam V; Hoffman CR; Russo K; Green MS
    Braz J Anesthesiol; 2019; 69(6):622-625. PubMed ID: 31784196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Malignant hyperthermia-like reactions in three anesthetized horses.
    Manley SV; Kelly AB; Hodgson D
    J Am Vet Med Assoc; 1983 Jul; 183(1):85-9. PubMed ID: 6874529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malignant hyperthermia in the ambulatory surgery center: how should we prepare?
    Litman RS; Joshi GP
    Anesthesiology; 2014 Jun; 120(6):1306-8. PubMed ID: 24710219
    [No Abstract]   [Full Text] [Related]  

  • 58. Fulminant-type malignant hyperthermia in Japan: cumulative analysis of 383 cases.
    Migita T; Mukaida K; Kawamoto M; Kobayashi M; Yuge O
    J Anesth; 2007; 21(2):285-8. PubMed ID: 17458663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Application of caffeine-halothane contracture test in the diagnosis of malignant hyperthermia].
    Wang YL; Guo XY; Xu ZH; Huang YG; Luo AL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Apr; 30(2):182-6. PubMed ID: 18505122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Malignant hyperthermia in the oral and maxillofacial surgery patient: an update.
    Patil PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):e1-7. PubMed ID: 21827956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.